Information

We use cookies to personalize content and ads and to analyze our traffic.
We also share information about your use of our site with our advertising and analytics partners. See details.

We use cookies to personalize content, ads, analyze traffic and share information about your use of our site. See details.

Home
|
|
|
Events
|
Press Releases
|
Subscribe
Type
Thought Leadership
Product Insight
Subscribe
Market and Economics
Portfolio and Risk Analysis
Companies and Earnings
Shareholder Distributions
ETFs
Fixed Income
Hedge Funds
M&A and Corporate Activism
Market Summaries
Category
Fact Sheets
Tools and Tips
Webcasts
White Papers

Is Icahn planning an increased stake in Nuance Communications?

Sep 2, 2015

On August 19, 2015, Nuance Communications, a U.S.-based company that provides voice and language solutions to businesses around the world, had a shareholder rights plan (poison pill) that expired. The poison pill provision, initially adopted in response to activist pressure, allowed shareholders to purchase additional shares if any one shareholder acquired more than 20% of the outstanding shares.

On August 8, 2013, activist investor Carl Icahn filed a passive 13G, disclosing a stake increase to approximately 16% of the company's common shares, up from 11%. As of September 2, 2015, Icahn now owns 19.4% of the company.

Monitor your firm's aggregate direct and indirect holdings and steer clear of the poison pill trigger with FactSet's new Poison Pill DataFeed. Easily identify holdings in your custody that may be impacted by a poison pill risk through seamless integration with FactSet's centralized reference data hub. Stay informed with coverage for more than 4,000 companies, updated daily.

Receive stories like this to your inbox as they are published. Subscribe by e-mail and follow @FactSet on Twitter.

© Copyright 2000 - FactSet Research Systems Inc.